Evidence map›Paper›PMID 39094833›Full record

ArticleJournal of the American Academy of Dermatology2024

Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data.

Daniella F Faden, Lillian Xie, Caroline J Stone, Lais Lopes Almeida Gomes, Ahmed Eldaboush, Cristina Ricco, Rui Feng, Victoria P Werth

Abstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniella F FadenCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Lillian XieCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Caroline J StoneCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Lais Lopes Almeida GomesCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Ahmed EldaboushCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cristina RiccoCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Rui FengDepartment of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
Victoria P WerthCorporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: werth@mail.med.upenn.edu.

Funding

Optimization of Clinical Trial Design in Cutaneous LupusR01AR071653 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI CHONG, BENJAMIN FRANKLIN, WERTH, VICTORIA P · 2018 to 2020
$653k
BLRD VA I01 BX005921NIAMS NIH HHS R01 AR071653
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trial eligibilitycutaneous lupus erythematosus (CLE)Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)disease severityquality of life (QoL)Skindex

Identifiers

PMID39094833
PMCPMC11910725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.